KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $9.9 billion.

  • Zimmer Biomet Holdings' Total Non-Current Liabilities rose 1933.57% to $9.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.9 billion, marking a year-over-year increase of 1933.57%. This contributed to the annual value of $7.8 billion for FY2024, which is 359.28% down from last year.
  • Zimmer Biomet Holdings' Total Non-Current Liabilities amounted to $9.9 billion in Q3 2025, which was up 1933.57% from $9.5 billion recorded in Q2 2025.
  • Over the past 5 years, Zimmer Biomet Holdings' Total Non-Current Liabilities peaked at $11.0 billion during Q2 2021, and registered a low of $7.6 billion during Q2 2024.
  • In the last 5 years, Zimmer Biomet Holdings' Total Non-Current Liabilities had a median value of $8.5 billion in 2022 and averaged $9.0 billion.
  • As far as peak fluctuations go, Zimmer Biomet Holdings' Total Non-Current Liabilities crashed by 2082.66% in 2022, and later soared by 2494.05% in 2025.
  • Quarter analysis of 5 years shows Zimmer Biomet Holdings' Total Non-Current Liabilities stood at $10.2 billion in 2021, then fell by 17.64% to $8.4 billion in 2022, then dropped by 3.85% to $8.1 billion in 2023, then fell by 3.59% to $7.8 billion in 2024, then rose by 27.25% to $9.9 billion in 2025.
  • Its last three reported values are $9.9 billion in Q3 2025, $9.5 billion for Q2 2025, and $8.9 billion during Q1 2025.